Harvard Bioscience Inc (HBIO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Harvard Bioscience Inc-Aktie (HBIO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.69% 20.59	20.45	21.77	24.56	21.97
Cost Of Revenue	3.89% 8.57	8.917	9.59	10.54	9.205
Gross Profit	4.23% 12.02	11.53	12.18	14.01	12.77
Operating Expenses	4.27% 11.82	12.35	61.85	14.00	14.64
Benefits Costs and Expenses	4.31% 21.73	22.70	72.57	23.97	26.46
Costs And Expenses	4.31% 21.73	22.70	72.57	23.97	26.46
Operating Income/Loss	124.05% 0.197	-0.819	-49.67	0.011	-1.874
Nonoperating Income/Loss	7.25% -1.331	-1.435	-1.126	0.579	-2.617
Income/Loss From Continuing Operations Before Tax	49.69% -1.134	-2.254	-50.79	0.59	-4.491
Income Tax Expense/Benefit	246.43% 0.097	0.028	-0.454	0.572	0.311
Income/Loss From Continuing Operations After Tax	46.06% -1.231	-2.282	-50.34	0.018	-4.802
Net Income/Loss	46.06% -1.231	-2.282	-50.34	0.018	-4.802
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.57% 44.56	44.30	44.10	0.039	43.61
Diluted Average Shares	0.57% 44.56	44.30	44.10	0.039	43.61
Basic Earnings Per Share	40.00% -0.03	-0.05	-1.14	0.010	-0.11
Diluted Earnings Per Share	40.00% -0.03	-0.05	-1.14	0.010	-0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SOLV

$66.76

0.97%

ALGN

$164.23

1.61%

COO

$69.92

2.24%

HOLX

$75.12

0.12%

WST

$235.46

1.89%

RMD

$230.84

0.68%